公开(公告)号：EP2400883B1

公开(公告)日：2018-12-12

申请号：EP10746602.1

申请日：2010-01-27

申请人： LifeScan, Inc.

发明人： KRULEVITCH, Peter ,  WILK, Robert ,  KRAFT, Ulrich ,  SAVAGE, Donna ,  FOLEY, Nick ,  GLENCROSS, James ,  SHEPHERD, David ,  SIEH, Zara ,  PRICE, David, M., D.

IPC分类号： A61M5/315 ,  A61M5/24 ,  G06F19/00 ,  A61B5/145 ,  G01D5/165

CPC分类号： A61M5/315 ,  A61B5/002 ,  A61B5/14532 ,  A61M5/24 ,  A61M5/3129 ,  A61M5/3146 ,  A61M5/31525 ,  A61M5/31551 ,  A61M2005/3126 ,  A61M2005/3142 ,  A61M2205/14 ,  A61M2205/18 ,  A61M2205/215 ,  A61M2205/3317 ,  A61M2205/3553 ,  A61M2205/3561 ,  A61M2205/3569 ,  A61M2205/3584 ,  A61M2205/3592 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/583 ,  A61M2205/584 ,  A61M2205/6054 ,  A61M2205/6081 ,  A61M2205/8212 ,  A61M2209/04 ,  G01D5/1655 ,  G06F19/00 ,  G06F19/3468

摘要： Various embodiments of a "smart" drug delivery pen are provided which include a drug delivery pen having an inertial sensor or accelerometer 276. A system is also provided that includes the smart drug pen in conjunction with a data management unit(s) DMU. The drug delivery pen also includes a momentary micro-switch 267 wherein depressing the injection knob 204 activates the momentary switch for waking up the device from sleep mode. Moreover, the duration of actuation of the micro-switch provides an indication whether the dose has been accurately delivered

公开(公告)号：EP2243502B1

公开(公告)日：2018-11-21

申请号：EP10007355.0

申请日：2003-09-04

申请人： Gambro Lundia AB

发明人： Bene, Bernard ,  Reitz, Carl W. ,  Vantard, Georges

IPC分类号： A61M1/16

CPC分类号： A61M1/16 ,  A61M1/1607 ,  A61M1/1609 ,  A61M1/1613 ,  A61M1/1617 ,  A61M2205/3317 ,  A61M2205/3324 ,  A61M2205/52 ,  A61M2230/65

摘要： Disclosed is a blood treatment equipment which is associated with or comprises a programmable controller adapted to receive entries of prescribed and measured information and to generate one or more control signals in response thereto. The equipment is characterised in that the controller is programmed to relate entries of measured information to prescribed dialysis dosage and weight loss value. Also disclosed are corresponding methods and program storage media.

公开(公告)号：EP3400037A1

公开(公告)日：2018-11-14

申请号：EP16829176.3

申请日：2016-12-22

申请人： Medtronic Xomed, Inc.

发明人： KOLTZ, Jr., Michael Lee ,  OMAR, Mansur Ibne

IPC分类号： A61M3/02 ,  G01F1/56 ,  G01F1/24

CPC分类号： G01F1/704 ,  A61B17/32 ,  A61B2217/007 ,  A61M3/022 ,  A61M3/0233 ,  A61M3/0254 ,  A61M2205/12 ,  A61M2205/3317 ,  A61M2205/3334 ,  A61M2205/3592 ,  A61M2205/60 ,  G01F1/24

摘要： A flow measurement assembly includes a coupler and a flow channel. The coupler maintains a magnet and a sensor spaced from the magnet. The flow channel is positionable between the magnet and the sensor. The flow channel includes a housing having an inlet, an outlet spaced from the inlet, and a flow conduit fluidly open to the inlet and the outlet. A ferrous body is movably disposed in the conduit. The sensor is configured to detect a frequency of a change within a magnetic field as the ferrous body travels within the flow conduit between the magnet and the sensor.

公开(公告)号：EP3389743A1

公开(公告)日：2018-10-24

申请号：EP16820512.8

申请日：2016-12-15

申请人： Avent, Inc.

发明人： HSU, Kenneth C. ,  KHALAJ, Steve Saeed ,  JUN, Paul D. ,  ROTELLA, John, A. ,  SHIPPY, III, James Lee

IPC分类号： A61M5/152 ,  A61M5/168

CPC分类号： A61M5/152 ,  A61M5/16813 ,  A61M5/16854 ,  A61M2205/3317 ,  A61M2205/3553

摘要： An elastomeric pump having at least one sensor for sensing changes in elongation of a bladder of the pump is provided. Also provided is an infusion assembly including an elastomeric pump having a bladder, at least one sensor for sensing changes in elongation of the bladder, and an indicator for providing one or more outputs of the sensor. The sensor may be a flexible sensor positioned in contact with the bladder of the pump, or a dielectric material may be incorporated into the material the bladder is made from such that the dielectric elastomer material of the bladder forms the sensor.

公开(公告)号：EP2506914B1

公开(公告)日：2018-10-17

申请号：EP10832750.3

申请日：2010-11-30

申请人： Roche Diabetes Care GmbH ,  F. Hoffmann-La Roche AG

发明人： YODFAT, Ofer ,  ZNATI, Eli ,  GESCHEIT, Illai ,  NETA, Avraham ,  LEVY, Offer

IPC分类号： A61M31/00

CPC分类号： A61M5/14248 ,  A61B5/1451 ,  A61B5/14532 ,  A61B5/14865 ,  A61B5/4839 ,  A61M5/002 ,  A61M5/1413 ,  A61M5/1456 ,  A61M5/1723 ,  A61M2005/14252 ,  A61M2005/14268 ,  A61M2005/1726 ,  A61M2205/3317 ,  A61M2205/3569 ,  A61M2205/3592 ,  A61M2209/01 ,  A61M2230/201

摘要： Embodiments of the present disclosure are directed to a skin adherable device for delivering therapeutic fluid into a body of a patient. In some embodiments, the device includes a monitoring apparatus, a pump, and a tip for delivering the therapeutic fluid into the body of the patient and for monitoring bodily analyte in the body of the patient. The pump may continuously deliver the therapeutic fluid to the body of the patient and the monitoring apparatus may continuously monitor bodily analytes of the patient.

公开(公告)号：EP1933913B1

公开(公告)日：2018-10-10

申请号：EP06780425.2

申请日：2006-08-21

申请人： HOSPITECH RESPIRATION LTD.

发明人： EFRATI, Shai ,  DEUTSCH, Israel

IPC分类号： A61M16/04

CPC分类号： A61M16/0051 ,  A61M16/024 ,  A61M16/044 ,  A61M16/0463 ,  A61M2016/0027 ,  A61M2016/0413 ,  A61M2205/15 ,  A61M2205/3303 ,  A61M2205/3306 ,  A61M2205/3317 ,  A61M2205/3327 ,  A61M2205/3334 ,  A61M2205/3344 ,  A61M2205/3375 ,  A61M2205/702 ,  A61M2210/0618 ,  A61M2230/432

摘要： A method of intubating a subject is disclosed. The method comprises inserting an endotracheal tube into the tracheal airway of the subject; inflating a cuff associated with the endotracheal tube within the airway below the vocal cords; measuring a level of at least one measure being indicative of leakage of secretion past the cuff to the lungs; comparing the level of the measure with an optimal level of the measure; and adjusting inflation of the cuff based on the comparison so as to generally minimize leakage of secretion from above the cuff to the lungs, while minimizing pressure associated damages to the airway. The measure(s) can be carbon dioxide concentration, a proxy measure from which such concentration can be inferred, or the level of one or more additives delivered to a subject during intubation.

公开(公告)号：EP3381489A1

公开(公告)日：2018-10-03

申请号：EP18161566.7

申请日：2018-03-13

申请人： B. Braun Melsungen AG

发明人： Stettner, Jens

IPC分类号： A61M5/168 ,  A61M5/152 ,  A61M5/145

CPC分类号： A61M5/14593 ,  A61M5/152 ,  A61M5/16854 ,  A61M2205/3317 ,  A61M2205/3337 ,  A61M2205/3382 ,  A61M2205/3584 ,  A61M2205/502 ,  A61M2205/587

摘要： Eine solche medizinische Pumpvorrichtung zur Förderung eines medizinischen Fluids mit einem Grundkörper und einer an dem Grundkörper festgelegten elastomeren Hohlmembran, die derart angeordnet ist, dass zwischen dem Grundkörper und der Hohlmembran ein Pumpvolumen zur Befüllung mit dem medizinischen Fluid gebildet ist, wobei die Hohlmembran in einem zumindest teilweise befüllten Füllzustand des Pumpvolumens elastisch gedehnt ist und derart einen Förderdruck auf das Pumpvolumen bewirkt, ist bekannt.
Erfindungsgemäß ist vorgesehen, dass die medizinische Pumpvorrichtung ein Sensoriksystem aufweist, das zur Ermittlung der Dehnung der Hohlmembran vorbereitet ist, so dass unter Verwendung der derart ermittelten Dehnung eine Füllstandsinformation zum Füllzustand des Pumpvolumens ermittelbar ist.
Einsatz bei Infusions- oder Transfusionsanordnungen

公开(公告)号：EP3377146A1

公开(公告)日：2018-09-26

申请号：EP16801056.9

申请日：2016-11-15

申请人： Advanced Microfluidics SA

发明人： BARRAUD, Antoine ,  KUENZI, Simon ,  RYSMAN, Rémy

IPC分类号： A61M5/142 ,  F04B19/00 ,  F04B43/00 ,  F04B43/09 ,  B65D1/00

CPC分类号： A61M5/14248 ,  A61M5/14224 ,  A61M5/16813 ,  A61M2005/14268 ,  A61M2205/3317 ,  A61M2207/00 ,  B29C69/02 ,  B29K2027/12 ,  B29L2031/7496 ,  F04B19/006 ,  F04B43/0072 ,  F04B43/043 ,  F04B43/09 ,  F04B43/095 ,  F04B49/22 ,  F04B53/1072

摘要： Micropump (10) including a support structure (14), a pump tube (16), and an actuation system (18) comprising one or more pump chamber actuators (28), the pump tube comprising a pump chamber portion (24) defining therein a pump chamber (26), an inlet portion (20) for inflow of fluid into the pump chamber, and an outlet portion (22) for outflow of fluid from the pump chamber. The inlet, outlet and pump chamber portions form part of a continuous section of tube made of a supple material. The one or more pump chamber actuators are configured to bias against the pump chamber portion to expel liquid contained in the pump chamber via the outlet portion, respectively to bias away from the pump chamber portion to allow liquid to enter the pump chamber via the inlet portion. The pump chamber portion has a cross-sectional area Ap in an expanded state that is larger than a cross-sectional area Ai of the pump tube at the inlet and outlet portions.

公开(公告)号：EP3374001A1

公开(公告)日：2018-09-19

申请号：EP16791414.2

申请日：2016-11-08

申请人： Gambro Lundia AB

发明人： HERTZ, Thomas

IPC分类号： A61M1/16 ,  A61M1/36

CPC分类号： A61M1/1607 ,  A61M1/1609 ,  A61M1/1613 ,  A61M1/3609 ,  A61M2205/3317 ,  A61M2230/20 ,  A61M2230/65

摘要： An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysis fluid circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid; a control unit (12) is configured for determining or receiving a proposed value (prop.value; Cprop.value) of a sodium concentration for the dialysis fluid in the dialysis supply line (8) and to determine a set value (fsetvalue; Cse tvalue) for the sodium concentration in the dialysis fluid as a function of the proposed value (prop.value; Cprop.value). For at least an interval of proposed values for the sodium concentration, the control unit (12) is configured to determine the set value so that the set value is different from the proposed value (prop.value; cprop.value) and so that distinct set values are determined from distinct proposed values. The set value is biased towards a predetermined pivot value that represents e.g. the average sodium concentration in the blood of a population and may not be outside a reference range.

公开(公告)号：EP3374000A1

公开(公告)日：2018-09-19

申请号：EP16791413.4

申请日：2016-11-08

申请人： Gambro Lundia AB

发明人： STERNBY, Jan

IPC分类号： A61M1/16

CPC分类号： A61M1/1607 ,  A61M1/16 ,  A61M1/1611 ,  A61M1/341 ,  A61M1/3413 ,  A61M1/3609 ,  A61M1/3653 ,  A61M2205/3317 ,  A61M2230/201 ,  A61M2230/65

摘要： An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysis fluid circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid; a control unit (12) is configured for determining or receiving a proposed value (Condprop) of a conductivity for the dialysis fluid in the dialysis supply line (8) and to determine a set value (Condset) for the conductivity in the dialysis fluid as a function of the proposed value (Condprop) and as a function of at least one of a second parameter (UF volume/W; WL/W) indicative of a patient fluid overload and a third parameter (gconc) chosen in the group including: a glucose concentration in the patient and a concentration-related parameter of at least glucose in the patient.